Automated Suturing Devices Market to Reach USD 7.5 Billion by 2036 as Medtronic Expands Surgical Leadership

According to the latest market analysis by Future Market Insights, the global Automated Suturing Devices Market is poised for sustained growth, supported by the increasing adoption of minimally invasive surgeries, rising integration of robotic surgical platforms, growing focus on infection control protocols, and the need for greater surgical efficiency across healthcare facilities.

The market is projected to grow from USD 3.8 billion in 2026 to USD 7.5 billion by 2036, registering a CAGR of 6.9% during the forecast period. The market was valued at USD 3.6 billion in 2025, reflecting growing adoption of automated tissue closure technologies across hospitals, clinics, and ambulatory surgical centers.

Quick Stats: Automated Suturing Devices Market:

• Market Value (2025): USD 3.6 Billion
• Estimated Market Size (2026): USD 3.8 Billion
• Forecast Market Value (2036): USD 7.5 Billion
• CAGR (2026-2036): 6.9%
• Incremental Opportunity (2026-2036): USD 3.65 Billion
• Leading Product Segment (2026): Disposable - 80.6% Share
• Leading Application Segment (2026): Minimally Invasive Surgeries - 75.8% Share
• Fastest Growing Markets: South Korea (7.2%) and USA (7.2%)

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-579

Market Overview and Key Growth Drivers

The automated suturing devices market is expanding as healthcare providers increasingly prioritize technologies that improve surgical efficiency, reduce operating room time, and enhance patient outcomes.

Minimally invasive surgeries remain the largest application segment, accounting for 75.8% of market demand in 2026. The continued shift toward laparoscopic, thoracoscopic, and robotic-assisted procedures is driving demand for advanced closure systems capable of operating through restricted access points.

Disposable automated suturing devices dominate the market with an 80.6% share, supported by stringent infection control protocols, sterility requirements, and growing regulatory preference for single-use surgical instruments that eliminate cross-contamination risks.

Market Size, Forecast, and Strategic Outlook

The market is expected to create an incremental opportunity of USD 3.65 billion between 2026 and 2036. Growth is being fueled by rising surgical volumes, increasing adoption of robotic-assisted surgery, and expanding utilization of automated closure solutions in outpatient surgical environments.

The industry is gradually transitioning from supplementary suturing tools toward fully integrated closure platforms designed for modern surgical workflows. As robotic surgery becomes more widespread across specialties, manufacturers are focusing on developing suturing systems that seamlessly integrate with robotic operating environments.

Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-579

Regional and Country-Level Insights

South Korea and the United States are expected to remain the fastest-growing markets, each registering a CAGR of 7.2% through 2036. Growth is supported by high minimally invasive surgery adoption rates, advanced surgical infrastructure, and increasing investments in robotic surgery technologies.

Japan is projected to expand at a CAGR of 7.1%, driven by strong domestic medical device manufacturing capabilities, early adoption of robotic surgery systems, and high procedural standards across healthcare facilities.

The European Union is anticipated to grow at 6.9%, supported by standardization of minimally invasive procedures, hospital modernization initiatives, and increasing preference for disposable surgical instruments.

Analyst Commentary

Sabyasachi Ghosh, Managing Director at Future Market Insights, states:

"Automated suturing devices are transitioning from specialty surgical tools to standard operating room infrastructure. Organizations that can deliver consistent closure quality, reduced procedure time, and compatibility with robotic surgical platforms are positioned to capture growing share during the forecast period."

Competitive Landscape

The global automated suturing devices market remains competitive, with leading medical device manufacturers focusing on robotic integration, procedural efficiency, and enhanced surgeon usability.

Medtronic plc maintains a leading market position through its broad surgical technology portfolio and integration with robotic surgery platforms. Ethicon (Johnson & Johnson) continues to strengthen its presence through advanced surgical closure solutions and extensive global distribution capabilities.

Other major participants include Apollo Endosurgery, Inc., BD (Becton, Dickinson and Company), Smith & Nephew plc, Boston Scientific Corporation, Stryker Corporation, Corza Medical, Peters Surgical, Mellon Medical, Dextera Surgical, and LSI Solutions.

Explore Industry Insights: https://www.futuremarketinsights.com/industry-analysis

Technology and Innovation Outlook

Innovation within the automated suturing devices market is increasingly centered on robotic compatibility, procedural automation, and enhanced precision closure technologies. Manufacturers are developing systems capable of improving workflow efficiency while reducing surgeon fatigue and variability in wound closure outcomes.

Robotic surgery integration continues to represent one of the strongest growth opportunities for the industry. Automated suturing solutions designed specifically for robotic platforms are gaining traction as hospitals expand investments in next-generation surgical technologies.

Market Drivers and Challenges

Key market drivers include rising minimally invasive surgery volumes, increasing robotic surgery adoption, growing infection control requirements, and demand for improved surgical productivity.

However, challenges remain, including the relatively high cost of automated suturing devices compared to traditional manual methods, procurement limitations in lower-volume facilities, and the need for clinical validation and surgeon training. Companies capable of balancing performance, affordability, and robotic compatibility are expected to gain competitive advantage.

Purchase Full Report for Detailed Insights: https://www.futuremarketinsights.com/reports/automated-suturing-devices-market

Why FMI: https://www.futuremarketinsights.com/why-fmi

Explore More Related Studies Published by FMI Research:

Absorbable Surgical Suture with Needle Market: https://www.futuremarketinsights.com/reports/absorbable-surgical-suture-with-needle-market

Absorbable PGA Surgical Sutures Market: https://www.futuremarketinsights.com/reports/absorbable-pga-surgical-sutures-market

3D Ready Organoid Expansion Service Market: https://www.futuremarketinsights.com/reports/3d-ready-organoid-expansion-service-market

Explore In-Depth Healthcare Market Insights: https://www.futuremarketinsights.com/industry-analysis/healthcare

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.